Halozyme Therapeutics reported $208.98M in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
DBV Technologies DBVT:US USD 2.07M 545K
Acadia Pharmaceuticals ACAD:US USD 130.71M 3.85M
Agios Pharmaceuticals AGIO:US USD 3.52M 2.07M
Alnylam Pharmaceuticals ALNY:US USD 264.31M 39.49M
Amarin AMRN:US USD 89.88M 4.56M
Amgen AMGN:US USD 6.84B 187M
Baxter International BAX:US USD 3.77B 27M
Cara Therapeutics CARA:US USD 10.81M 12.19M
Cytokinetics CYTK:US USD 2.51M 86.45M
Eli Lilly And LLY:US USD 7.3B 360.2M
Esperion Therapeutics ESPR:US USD 18.98M 139K
Halozyme Therapeutics HALO:US USD 208.98M 56.61M
Immunogen IMGN:US USD 15.38M 1.21M
Intercept Pharmaceuticals ICPT:US USD 77.59M 5.83M
Intra Cellular Therapies ITCI:US USD 71.87M 16.29M
Intrexon XON:US USD 16.72M 13.81M
IONIS PHARMACEUT IONS:US USD 159.77M 25.98M
JAZZ PHA JAZZ:US USD 940.65M 7.77M
Mannkind MNKD:US USD 32.82M 13.93M
Nektar Therapeutics NKTR:US USD 23.62M 2.04M
Peregrine Pharmaceuticals PPHM:US USD 34.76M 1.93M
Pfizer PFE:US USD 24.29B 1.65B
Rigel Pharmaceuticals RIGL:US USD 22.41M 7.41M
United Therapeutics UTHR:US USD 516M 49.1M
Vanda Pharmaceuticals VNDA:US USD 65.32M 63.46M